Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised e vidence

This publication has 34 references indexed in Scilit:

• A Controlled Trial of Zidovudine in Primary Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1995
• A Comparison of Immediate with Deferred Zidovudine Therapy for Asymptomatic HIV-Infected Adults with CD4 Cell Counts of 500 or More per Cubic Millimeter
  New England Journal of Medicine, 1995
• Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
  The Lancet, 1994
• Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS
  AIDS, 1994
• Randomized double‐blind, placebo‐controlled trial of twice‐daily zidovudine in asymptomatic haemophiliacs infected with the human immunodeficiency virus type 1
  British Journal of Haematology, 1994
• Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter
  New England Journal of Medicine, 1993
• Placebo-controlled trial to evaluate zidovudine in treatment of human immunodeficiency virus infection in asymptomatic patients with hemophilia. NHF-ACTG 036 Study Group
  Blood, 1991
• The Safety and Efficacy of Zidovudine (AZT) in the Treatment of Subjects with Mildly Symptomatic Human Immunodeficiency Virus Type 1 (HIV) Infection
  Annals of Internal Medicine, 1990
• Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1990
• The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related Complex
  New England Journal of Medicine, 1987